GSK Pharma to infuse Rs 1,000 cr in pharmaceutical unitIllustrative image – not actual.

Pharmaceutical and healthcare company, GlaxoSmithKline is making an investment of Rs 1,000 crore in its new pharmaceutical factory in Vemgal, Karnataka.

The company is looking forward to expanding its footprint in the area of respiratory drugs and vaccines in India.

The plant will initially supply a range of solid dose form products. The factory will manufacture over eight billion tablets and one billion capsules a year. Production will commence in 2018.

The pharmaceutical company is also upgrading its existing facility in Nashik, Maharashtra. GSK India has made an investment of Rs 115 crore to build a facility to manufacture Eltroxin, which will be fully operational in 2018.

 

← All latest storiesBack to top →